TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today confirmed that its binding letter of intent with Vigilance, Inc., which was previously announced by the Company on June 16, 2014, has been terminated after several rounds of negotiations with the Vigilance Board of Directors failed in developing acceptable terms for entering into a definitive long term working relationship.
“As acknowledged in our June press release, CardioComm Solutions’ remote patient ECG monitoring technology platforms can allow diagnostic patient monitoring organizations to cross multiple monitoring verticals and offers a fit for technology development initiatives, data acquisition goals and growth objectives. Despite best efforts, we could not progress in establishing a business model that could meet the requirements of both organizations. At this point, CardioComm Solutions has decided to move ahead in its efforts to solidify our technology provider relationships with established cardiology-based clinical providers, monitoring services, and wireless device manufacturers,” stated Etienne Grima, Chief Executive Officer of CardioComm Solutions.
More information about GEMS™ WIN and GlobalCardio™ can be found at the Company’s website www.cardiocommsolutions.com.
